| ASHAs |
Facilitators and barriers experienced in delivering the intervention in the community Perception about effectiveness of different intervention components like anti-stigma campaign, technology-based decision support system and use of IVRS Perceptions on training appropriateness, effectiveness and methods Factors that influenced treatment seeking by high-risk cohort Overall experience of participating in the trial
|
1 |
8 |
| Project field staff |
Barriers or facilitators experienced in implementation of the intervention Perceived factors which explain high/low treatment seeking in different PHCs Key challenges and lessons learnt in implementation of intervention components like antistigma campaign, technology-based decision support system and use of IVRS -
Views on impact of the intervention in the community
Perceptions on training appropriateness, effectiveness and methods
|
|
3 |
Study participants from high-risk cohort in intervention arm who sought treatment
(To purposively select individuals who (1) went to PHC (2) Went to camp (3) got treated by psychiatrist (4) started treatment but discontinued) |
Perceptions about different intervention components like antistigma campaign, technology-based decision support system and use of IVRS Facilitators and barriers in treatment seeking Experience of care and perception about quality of care Perceived benefit if any as a result of treatment received Positive/negative experiences as a study participant Perception about benefits/effectiveness of the intervention
|
2
(1 with men one with women) |
12 |
| Study participants from non-high-risk cohort in the intervention arm |
Perception about the different components of the antistigma campaign (eg, Live drama, pamphlets etc) Key takeaway messages from the antistigma campaign Perceived changes if any related to mental health stigma Positive/negative experiences as study participant
|
2
(One with men and one with women) |
12 |
| Study participants from high-risk cohort in the control arm (including both who sought treatment and who did not seek treatment) |
Reasons for seeking or not seeking care Facilitators and barriers in the community to seeking care for CMDs Experience as a study participant
|
2
(One with men and one with women) |
4 |
| Total FGDs |
|
|
39 |
| In-depth Interviews |
| PHC doctors |
Experience of using technology-based decision support system to diagnose and manage CMDs Challenges faced in trial participating Perceived effectiveness of intervention components (antistigma campaign, mHealth) in improving management of CMDs in the community. Possible facilitators and barriers to scaling up Overall experience of participating in the trial
|
1 |
8 |
| Village heads/community leaders of the village |
Their role in this programme if any Views about the programme and its impact Feedback and suggestion if any
|
1 |
8 |
| Study participants from high-risk cohort in intervention arm who who did not seek treatment |
Perceptions about different intervention components like antistigma campaign, technology-based decision support system and use of IVRS Reasons for not seeking care Facilitators and barriers in treatment seeking Positive/negative experiences as a study participant Perception about benefits/effectiveness of the intervention
|
1 |
12 |
| Government health officials |
Perception about effectiveness of the intervention in reducing treatment gap for CMDs Perceived facilitators and challenges in scaling up the intervention Their role if any in the programme
|
2 (per district) |
6 |
| Total interviews |
|
|
24 |
